Email marketing automation: best practices. How templating framework will drive brand identity based on pre-approved content

The webinar either no longer exists or an error has occured.

Please enter your email to download the file

How many marketers are there in pharma who could do without emailing? This non-intrusive, yet quite engaging channel is the perfect supplement to whatever the reps have to say – and yes, it can be quite engaging if you know how to create good emails. According to fresh data from the U.S., over half enterprises are planning an increase in email budget – and still, about 54% feel they don’t use the full automation potential.

In healthcare, this potential is the doorway to real informational value. While supplying high-quality digital content for medical sphere is a process to be taken very seriously, this isn’t a reason why such emails shouldn’t be created fast enough to be relevant.

The free webinar on February 15th, 2018 (4 PM CET) is specifically dedicated to the best practices in life sciences email content. Within half an hour, the following issues will be covered:

  • Building quality personalized emails from predesigned blocks of corporate assets;
  • Increasing cost-efficiency with templating approach to content;
  • Keeping consistent branding throughout the organization and managing content approval for building blocks and fragments.

You can register for the webinar via this link or using the form below – and be up to date on what emailing can do to bring your brand even closer to HCP audience.

The event has already taken place. Registration is closed.

However, you can request this webinar recording.
It will be sent to your email box. Just fill out the following form:

The recording is not available yet.

Related Events

  • No events in this category
  • Register NOW

    Details

    Date:
    15/02/2018
    Time:
    16:00 - 16:30
    Cost:
    FREE

    Organizer

    Viseven
    Phone:
    +372 69 80 467
    Email:
    info@viseven.com
    2018-01-29T12:10:35+00:00 Thursday, 15 February 2018|